MCID: HMT018
MIFTS: 40

Hematopoietic Stem Cell Transplantation

Categories: Rare diseases, Blood diseases

Aliases & Classifications for Hematopoietic Stem Cell Transplantation

MalaCards integrated aliases for Hematopoietic Stem Cell Transplantation:

Name: Hematopoietic Stem Cell Transplantation 38 56

Characteristics:

Orphanet epidemiological data:

56
hematopoietic stem cell transplantation
Inheritance: Not applicable; Prevalence: 1-9/1000000 (Europe);

Classifications:



External Ids:

Orphanet 56 ORPHA90053
ICD10 via Orphanet 34 Z94.8

Summaries for Hematopoietic Stem Cell Transplantation

MalaCards based summary : Hematopoietic Stem Cell Transplantation is related to hepatic veno-occlusive disease and aspergillosis. An important gene associated with Hematopoietic Stem Cell Transplantation is ARHGAP45 (Rho GTPase Activating Protein 45). The drugs Micafungin and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include t cells, bone and myeloid.

Wikipedia : 72 Hematopoietic stem cell transplantation (HSCT) is the transplantation of multipotent hematopoietic stem... more...

Related Diseases for Hematopoietic Stem Cell Transplantation

Diseases related to Hematopoietic Stem Cell Transplantation via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 347)
id Related Disease Score Top Affiliating Genes
1 hepatic veno-occlusive disease 11.6
2 aspergillosis 11.4
3 chronic granulomatous disease 11.4
4 juvenile myelomonocytic leukemia 11.4
5 chronic active epstein-barr virus infection 11.3
6 shwachman-diamond syndrome 11.3
7 krabbe disease 11.3
8 c1q deficiency 11.3
9 chediak-higashi syndrome 11.3
10 leukocyte adhesion deficiency, type iii 11.3
11 plasmablastic lymphoma 11.3
12 hemophagocytic lymphohistiocytosis, familial, 1 11.0
13 fanconi anemia, complementation group a 11.0
14 specific granule deficiency 2 11.0
15 hemophagocytic lymphohistiocytosis, familial, 4 11.0
16 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 11.0
17 atypical mycobacteriosis, familial 11.0
18 thrombocytopenia, congenital amegakaryocytic 11.0
19 benta disease 11.0
20 leukemia 10.8
21 lymphoma 10.6
22 acute graft versus host disease 10.6
23 chronic graft versus host disease 10.5
24 myeloid leukemia 10.5
25 bronchiolitis 10.5
26 bronchiolitis obliterans 10.5
27 aplastic anemia 10.5
28 acute leukemia 10.5
29 hemorrhagic cystitis 10.4
30 cystitis 10.4
31 multiple myeloma 10.4
32 hepatitis 10.4
33 myelodysplastic syndrome 10.4
34 lymphoblastic leukemia 10.4
35 severe combined immunodeficiency 10.4
36 t-cell leukemia 10.4
37 invasive aspergillosis 10.3
38 adult t-cell leukemia 10.3
39 pneumonia 10.3
40 thalassemia 10.3
41 engraftment syndrome 10.3
42 endotheliitis 10.3
43 cytomegalovirus infection 10.2
44 neutropenia 10.2
45 pure red-cell aplasia 10.2
46 dyskeratosis congenita 10.2
47 encephalitis 10.2
48 hodgkin lymphoma 10.2
49 hemolytic anemia 10.2
50 osteopetrosis 10.2

Graphical network of the top 20 diseases related to Hematopoietic Stem Cell Transplantation:



Diseases related to Hematopoietic Stem Cell Transplantation

Symptoms & Phenotypes for Hematopoietic Stem Cell Transplantation

Drugs & Therapeutics for Hematopoietic Stem Cell Transplantation

Drugs for Hematopoietic Stem Cell Transplantation (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 608)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Micafungin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 235114-32-6 3081921 477468
2
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 22916-47-8 4189
3
Azacitidine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 320-67-2 9444
4
Decitabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 2353-33-5 451668
5
Cyclophosphamide Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
6
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 33419-42-0 36462
7
Teniposide Approved Phase 4,Phase 2 29767-20-2 34698
8
Idarubicin Approved Phase 4,Phase 3,Phase 2,Phase 1 58957-92-9 42890
9
Iron Approved Phase 4,Phase 2,Phase 3,Phase 1 7439-89-6 23925
10
Methotrexate Approved Phase 4,Phase 2,Phase 3,Phase 1 1959-05-2, 59-05-2 126941
11
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 104987-11-3 445643 439492
12
Busulfan Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 55-98-1 2478
13
Fludarabine Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 21679-14-1, 75607-67-9 30751
14
Vidarabine Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 24356-66-9 32326 21704
15
Posaconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1 171228-49-2 147912
16
Voriconazole Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 137234-62-9 71616
17
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 147-94-4 6253
18
Basiliximab Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 152923-56-3, 179045-86-4
19
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 128794-94-5 5281078
20
Mycophenolic acid Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 24280-93-1 446541
21
Foscarnet Approved Phase 4,Phase 3,Phase 2 63585-09-1, 4428-95-9 3415
22
Ganciclovir Approved, Investigational Phase 4,Phase 3,Phase 2 82410-32-0 3454
23
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-02-2 5743
24
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
25
Deferasirox Approved, Investigational Phase 4,Phase 2 201530-41-8 5493381
26
Itraconazole Approved, Investigational Phase 4,Phase 3,Phase 2 84625-61-6 55283
27
Protein C Approved Phase 4
28
Menthol Approved Phase 4,Phase 2,Phase 1 2216-51-5 16666
29
Aprepitant Approved, Investigational Phase 4 170729-80-3 151165 6918365
30
Fosaprepitant Approved Phase 4 172673-20-0 219090
31
Nystatin Approved, Vet_approved Phase 4,Phase 3 1400-61-9 11953884
32
Hydroxocobalamin Approved Phase 4 13422-51-0 11953898 5460373 44475014
33
Ledipasvir Approved Phase 4 1256388-51-8 67505836
34
Sofosbuvir Approved Phase 4 1190307-88-0 45375808
35
Peginterferon alfa-2b Approved Phase 4 99210-65-8, 215647-85-1
36
Colistin Approved Phase 4 1264-72-8, 1066-17-7 5311054
37
Tropisetron Approved, Investigational Phase 4 105826-92-4, 89565-68-4 5595
38
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 59-30-3 6037
39
leucovorin Approved, Nutraceutical Phase 4,Phase 2,Phase 3,Phase 1 58-05-9 143 6006
40
Cholecalciferol Approved, Nutraceutical Phase 4,Phase 2 67-97-0 6221 10883523 5280795
41
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 1,Phase 2 50-14-6 5280793
42
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4,Phase 1,Phase 2 1406-16-2
43
Cyanocobalamin Approved, Nutraceutical Phase 4 68-19-9 44176380
44
Phosphonoacetic Acid Experimental Phase 4,Phase 3,Phase 2 4408-78-0 546
45
Treosulfan Investigational Phase 4,Phase 3,Phase 2,Phase 1 299-75-2 9296
46
Substance P Investigational Phase 4 33507-63-0 44359816
47 Antifungal Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
48 Anti-Infective Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
49 Echinocandins Phase 4,Phase 3,Phase 2,Phase 1
50 Antimetabolites Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 1978)

id Name Status NCT ID Phase Drugs
1 Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation Unknown status NCT01135589 Phase 4 Micafungin
2 Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCT Unknown status NCT01379391 Phase 4 Recombinant Human Thrombopoietin (rHTPO)
3 Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation Unknown status NCT01806116 Phase 4 decitabine
4 ATG Could Improve the Outcome Of Hematopoietic Stem Cell Transplant in Patients With Highly Aggressive T Cell Tumors Unknown status NCT02290132 Phase 4 Rabbit Anti-human Thymocyte Globulin (ATG)
5 HD-Idarubicin/Etoposide Intensified Conditioning Regimen Allo-HSCT for Adult ALL Unknown status NCT01873807 Phase 4 IDA;CTX;VP-16
6 Intrabone Cord Blood Transplantation Unknown status NCT00838019 Phase 4
7 Post Hematopoietic Stem Cell Transplantation Completed NCT01610297 Phase 4 ICL670
8 Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation Fro Completed NCT02660684 Phase 4 Prograf;Methotrexate;Cyclosporine
9 Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation Completed NCT00336531 Phase 4 itraconazole
10 Open-Label Single-Arm Pilot Study in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload Completed NCT01335035 Phase 4 deferasirox
11 Glutamine Popsicles in Bone Marrow Transplant (BMT)/Hematopoietic Stem Cell Transplant (HSCT) Patients Completed NCT00204958 Phase 4 nutritional supplement;glutamine popsicle
12 Bronchodilator Responsiveness in Obliterative Bronchiolitis Completed NCT01112241 Phase 4 albuterol plus tiotropium
13 Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload Completed NCT00654589 Phase 4 Deferasirox
14 A Safety Evaluation of Drotrecogin Alfa (Activated) in Patients With Blood Cancer, Severe Infection Related to Bone Marrow Transplantation Completed NCT00067730 Phase 4 Drotrecogin Alfa (activated)
15 Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) Completed NCT00361140 Phase 4 Busulfan;Fludarabine
16 Adjuvanted Influenza Vaccine in Stem Cell Transplant Completed NCT02560909 Phase 4
17 A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area Completed NCT02372357 Phase 4 Posaconazole prophylaxis 120 mg/m² tid
18 Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation Completed NCT01738373 Phase 4 Plerixafor
19 A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing Completed NCT01416025 Phase 4 Prospective TDM Arm
20 SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia Completed NCT00487448 Phase 4 Fludarabine;Cytarabine;G-CSF;Idarubicin
21 Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation Recruiting NCT03010579 Phase 4 erythropoietin;iron supplementation
22 Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major Recruiting NCT03171831 Phase 4 Busulfan;Cyclophosphamide;Fludarabine;Mycophenolate mofetil;Tacrolimus;Methotrexate;Thymoglobulin;Basiliximab
23 Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major Recruiting NCT02342145 Phase 4 Basiliximab,;cyclosporine A;Methotrexate;Mycophenolate mofetil
24 PEG-rhG-CSF in Lymphoma Patients After Autologous Hematopoietic Stem Cell Transplantation Recruiting NCT02905942 Phase 4 PEG-rhG-CSF;rhG-CSF
25 Ledipasvir/Sofosbuvir Treatment for Hepatitis C in HCT Recipients. Recruiting NCT03279133 Phase 4 Ledipasvir 90mg/Sofosubvir 400mg
26 CMV-CTL for the Treatment of CMV Infection After HSCT Recruiting NCT03004261 Phase 4 Foscarnet;Ganciclovir
27 Post-transplantation Cyclophosphamide for Haploidentical Transplant From Maternal or Collateral Donors Recruiting NCT02412423 Phase 4 post-transplantation cyclophosphamide
28 Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors Recruiting NCT02929615 Phase 4
29 Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients Recruiting NCT03150134 Phase 4 Cyclosporine;routine reduction of immunosuppressive drugs(cyclosporine)
30 Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT Recruiting NCT02634294 Phase 4 Peg interferon alfa-2b
31 ALL SCTped FORUM - Pharmacogenomic Study (add-on Study) Recruiting NCT02670564 Phase 4
32 ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors Recruiting NCT02938741 Phase 4 Anti-human Thymoglobulin;Placebo
33 Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE Recruiting NCT01491763 Phase 4 Imatinib
34 A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy Recruiting NCT03150602 Phase 4 Pralatrexate
35 A Study of DEcolonization in Patients With HAematological Malignancies (DEHAM) Recruiting NCT02966457 Phase 4 Colistimethate Sodium
36 A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation Active, not recruiting NCT02576327 Phase 4 Tropisetron;Dexamethasone;Aprepitant
37 Oral Hygiene Regimen in Patients on HCT Enrolling by invitation NCT02662374 Phase 4 .02% Chlorohexidine Gluconate;3% Sodium Bicarbonate;Nystatin 10000U/ml;Supersaturated Calcium Phosphate
38 A Optimal Anti-Thymoglobuline (ATG) Dose Decrease cGVHD But Not Increase Leukemia Relapse for Haplo-HSCT Not yet recruiting NCT03190733 Phase 4 ATG
39 A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT Not yet recruiting NCT03176849 Phase 4
40 King's Invasive Aspergillosis Study II Not yet recruiting NCT02875743 Phase 4 Posaconazole
41 Eltrombopag in Children With Idiopathic Aplastic Anemia Not yet recruiting NCT03243656 Phase 4 Eltrombopag
42 Evaluation of Antifungal Prophylaxis on Graft-versus-host Disease (GVHD) Patients Terminated NCT01282879 Phase 4 Itraconazole
43 Hematopoietic Stem Cell Transplantation for Mucopolysaccharidosis Unknown status NCT01238328 Phase 2, Phase 3 Conditioning regimen;Graft-versus-host disease (GVHD) prophylaxis
44 Hematopoietic Stem Cell Transplantation for Malignant Infantile Osteopetrosis Unknown status NCT01087398 Phase 2, Phase 3 Busulfan, Cyclophosphamide, Thymoglobulin, Fludarabine (Conditioning regimen);Cyclosporin, Methotrexate (GVHD prophylaxis)
45 Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation Unknown status NCT02313792 Phase 3 Palifermin
46 Hematopoietic Stem Cell Transplantation in Myeloma Unknown status NCT00415987 Phase 2, Phase 3
47 Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation Unknown status NCT01800643 Phase 2, Phase 3
48 Allogeneic Transplantation For Severe Osteopetrosis Unknown status NCT00775931 Phase 2, Phase 3 Campath-1H;Cyclophosphamide;Busulfan;Fludarabine monophosphate
49 Lactobacillus Brevis CD2 Preventing Oral Mucositis Unknown status NCT02085694 Phase 2, Phase 3 Lactobacillus brevis CD2
50 T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders Unknown status NCT00176826 Phase 2, Phase 3 Myeloablative conditioning regimen

Search NIH Clinical Center for Hematopoietic Stem Cell Transplantation

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Stem-cell-based therapeutic approaches for Hematopoietic Stem Cell Transplantation:
ATIR
Bone marrow-derived mesenchymal stem cells combined with cord blood for treatment of graft failure
Bone marrow-derived mesenchymal stem cells for treatment of poor graft function
Embryonic/Adult Cultured Cells Related to Hematopoietic Stem Cell Transplantation:
ATIR PMIDs: 17977031 17878399 23206844 20798236 12091325
Bone marrow-derived mesenchymal stem cells

Genetic Tests for Hematopoietic Stem Cell Transplantation

Anatomical Context for Hematopoietic Stem Cell Transplantation

MalaCards organs/tissues related to Hematopoietic Stem Cell Transplantation:

39
T Cells, Bone, Myeloid, Bone Marrow, B Cells, Kidney, Breast

Publications for Hematopoietic Stem Cell Transplantation

Articles related to Hematopoietic Stem Cell Transplantation:

(show top 50) (show all 1764)
id Title Authors Year
1
Allogeneic hematopoietic stem cell transplantation for refractory mycosis fungoides (MF) and Sezary syndrome (SS). ( 28466385 )
2017
2
Pharmacokinetic Interaction Between Tacrolimus and Fentanyl in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation. ( 28947731 )
2017
3
Topical Cidofovir for Recalcitrant Verrucae in Individuals with Severe Combined Immunodeficiency After Hematopoietic Stem Cell Transplantation. ( 27699886 )
2017
4
Tyrosine Kinase Inhibitor for Treatment of Adult Allogeneic Hematopoietic Stem Cell Transplantation Candidate with Philadelphia-Positive Acute Lymphoblastic Leukemia. ( 28091401 )
2017
5
Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization. ( 28067885 )
2017
6
Hyponatremia associated with human herpesvirus-6 (HHV-6) encephalitis after allogeneic hematopoietic stem cell transplantation: A presentation different from HHV-6 myelitis. ( 28501929 )
2017
7
Cryptococcus laurentii diarrhea post hematopoietic stem cell transplant. ( 28083955 )
2017
8
Early hematopoietic stem cell transplantation in a patient with severe mucopolysaccharidosis II: A 7A years follow-up. ( 28649514 )
2017
9
Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation. ( 28481355 )
2017
10
HLA-E mismatch is associated with better hematopoietic stem cell transplantation outcome in acute leukemia patients. ( 28883078 )
2017
11
Hematopoietic stem cell transplantation for the treatment of leukocyte adhesion deficiency type III. ( 28827066 )
2017
12
Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia harboring trisomy 8. ( 28058493 )
2017
13
Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral Adrenoleukodystrophy. ( 28418523 )
2017
14
Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation. ( 28938875 )
2017
15
Prospective Study of a Cohort of Russian Nijmegen Breakage Syndrome Patients Demonstrating Predictive Value of Low Kappa-Deleting Recombination Excision Circle (KREC) Numbers and Beneficial Effect of Hematopoietic Stem Cell Transplantation (HSCT). ( 28791007 )
2017
16
Myeloablative hematopoietic stem cell transplantation improves survival but is not curative in a pre-clinical model of myelodysplastic syndrome. ( 28953912 )
2017
17
Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation. ( 28092355 )
2017
18
Correction: Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. ( 28938702 )
2017
19
Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome in a Child With Klinefelter Syndrome. ( 28902077 )
2017
20
Conjugated Estrogen in Late-Onset Hemorrhagic Cystitis Associated with Hematopoietic Stem Cell Transplantation. ( 28286609 )
2017
21
Sphingosine 1-Phosphate Signaling and Its Pharmacological Modulation in Allogeneic Hematopoietic Stem Cell Transplantation. ( 28934113 )
2017
22
Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. ( 27766393 )
2017
23
Acanthamoeba granulomatous amoebic encephalitis after pediatric hematopoietic stem cell transplant. ( 28921764 )
2017
24
Phase I Study of Clofarabine and 2-Gy Total Body Irradiation as a Nonmyeloablative Preparative Regimen for Hematopoietic Stem Cell Transplantation in Pediatric Patients with Hematologic Malignancies: A Therapeutic Advances in Childhood Leukemia Consortium Study. ( 28396162 )
2017
25
Population Pharmacokinetics and Optimal Sampling Strategy for Model-Based Precision Dosing of Melphalan in Patients Undergoing Hematopoietic Stem Cell Transplantation. ( 28918602 )
2017
26
Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial. ( 28920142 )
2017
27
The Effect of CCR5I932 on the Risk of Grade 3-4 Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. ( 28862353 )
2017
28
Everyday life following hematopoietic stem cell transplantation: decline in physical symptoms within the first month and change-related predictors. ( 28900828 )
2017
29
Impact of Toxicity on Survival for Older Adult Patients after CD34+ Selected Allogeneic Hematopoietic Stem Cell Transplantation. ( 28951193 )
2017
30
Risk factors in patients undergoing haploidentical hematopoietic stem cell transplantation for high-risk childhood acute leukemia. ( 28825215 )
2017
31
Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II. ( 28673849 )
2017
32
Vascular and perivascular niches, but not the osteoblastic niche, are numerically restored following allogeneic hematopoietic stem cell transplantation in patients with aplastic anemia. ( 28303517 )
2017
33
Chimerism in pediatric hematopoietic stem cell transplantation and its correlation with the clinical outcome. ( 28951259 )
2017
34
Successful Treatment of BK Virus Hemorrhagic Cystitis (HC) Post Allogenic Hematopoietic Stem Cell Transplantation with Low Dose Cidofovir. ( 28598058 )
2017
35
Effect of donor STAT4 polymorphism rs7574865 on clinical outcomes of pediatric acute leukemia patients after hematopoietic stem cell transplant. ( 27960128 )
2017
36
Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results. ( 28067873 )
2017
37
Economic burden following allogeneic hematopoietic stem cell transplant in patients with diffuse large B-cell lymphoma. ( 28933643 )
2017
38
Outcome of autologous hematopoietic stem cell transplantation in refractory multiple myeloma. ( 28513828 )
2017
39
Palliative Care Integration in Hematopoietic Stem-Cell Transplantation: The Need for Additional Research. ( 28898606 )
2017
40
Disseminated Lichtheimia ramosa Infection After Hematopoietic Stem Cell Transplantation in a Child with Chronic Granulomatous Disease. ( 28333712 )
2017
41
Expansion of cytotoxic CD56(bright) natural killer cells during T-cell deficiency after allogeneic hematopoietic stem cell transplantation. ( 28778795 )
2017
42
Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation. ( 28892085 )
2017
43
Incidence and Outcome of Pericardial Effusion in Pediatric Patients After Hematopoietic Stem Cell Transplant: A Single-institution Experience. ( 28945662 )
2017
44
Lung transplantation for bronchiolitis obliterans syndrome after allogenic hematopoietic stem cell transplantation. ( 28752350 )
2017
45
Quality of life among boys with adrenoleukodystrophy following hematopoietic stem cell transplant. ( 28934891 )
2017
46
Early abnormal liver enzyme levels may increase the prevalence of human cytomegalovirus antigenaemia after hematopoietic stem cell transplantation. ( 28415934 )
2017
47
Characteristics and risk of chronic graft-versus-host disease of liver in allogeneic hematopoietic stem cell transplant recipients. ( 28934311 )
2017
48
Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial. ( 28752258 )
2017
49
Dismal outcome of allogeneic hematopoietic stem cell transplantation for relapsed adult T-cell leukemia/lymphoma, a Japanese nation-wide study. ( 28067877 )
2017
50
Evaluation of Serum Interleukin-21 and HLA-C1 Polymorphism in Pediatrician Hematopoietic Stem Cell Transplantation for Early Diagnosis of Acute Graft-Versus-Host Disease ( 28627158 )
2017

Variations for Hematopoietic Stem Cell Transplantation

Expression for Hematopoietic Stem Cell Transplantation

Search GEO for disease gene expression data for Hematopoietic Stem Cell Transplantation.

Pathways for Hematopoietic Stem Cell Transplantation

GO Terms for Hematopoietic Stem Cell Transplantation

Sources for Hematopoietic Stem Cell Transplantation

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....